1620 Investment Advisors »

United Therapeutics Corporation shares owned by 1620 Investment Advisors

Quarter-by-quarter ownership of United Therapeutics Corporation (UTHR) shares owned by 1620 Investment Advisors from 13F filings

Historical chart of 1620 Investment Advisors investment in United Therapeutics Corporation

Tip: Access up to 7 years of quarterly data

All positions including United Therapeutics Corporation held by 1620 Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in United Therapeutics Corporation by 1620 Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $144k 403 358.35
2024-06-30 $123k 386 318.55

More positions owned by 1620 Investment Advisors

SPDR Portfolio Intrmdt Term Corp Bd ETF Etf (SPIB)
iShares 7-10 Year Treasury Bond ETF Etf (IEF)
SPDR MSCI EAFE StrategicFactors ETF Etf (QEFA)
SPDR S&P 600 Small Cap ETF Etf
Tri Continental Corporation Etf (TY)
SPDR Ptf Short-Term Treasury ETF Etf (SPTS)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
TJX Companies (TJX)
iShares Short Term Ntnl Muni Bond ETF Etf (SUB)
iShares Short-Term Corporate Bond ETF Etf (IGSB)
Microsoft Corporation (MSFT)
Freedom 100 Emerging Markets ETF Etf (FRDM)
Schwab U.S. TIPS ETF Etf (SCHP)
SPDR Doubleline Total Return Tactical ETF Etf (TOTL)

View all positions for 1620 Investment Advisors

Top funds holding United Therapeutics Corporation

Wealthfront Advisers
BlackRock
Vanguard Group
venBio Select Advisor
Wellington Management Company
State Street Corporation
Renaissance Technologies
FMR
Geode Capital Management
AQR Capital Management
LSV Asset Management
Alliancebernstein
Dimensional Fund Advisors
Pacer Advisors
Arrowstreet Capital, Limited Partnership

View all funds holding United Therapeutics Corporation